444(top 19%)
articles
19.5K(top 12%)
citations
80(top 17%)
★★ articles
12(top 8%)
★★★ articles
3.4(top 9%)
Avg IF
70(top 11%)
H-Index
136(top 9%)
G-Index
171
journals

Most Cited Articles of British Heart Foundation in 2020

TitleJournalYearCitations
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19New England Journal of Medicine20201.3K
Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysisBMJ, The2020174
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million peopleHeart2020174
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathologyEBioMedicine2020155
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without DiabetesJAMA - Journal of the American Medical Association2020155
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart FailureCirculation2020145
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failureNature Communications2020140
The 'Digital Twin' to enable the vision of precision cardiologyEuropean Heart Journal2020136
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialsLancet, The2020133
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF TrialCirculation2020130
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trustEuropean Journal of Heart Failure2020127
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort studyJournal of Infection2020115
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study GroupEuropean Heart Journal2020106
High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19Circulation2020106
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialNephrology Dialysis Transplantation2020105
The Polygenic and Monogenic Basis of Blood Traits and DiseasesCell202096
Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global PopulationsCell202088
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failureEuropean Journal of Heart Failure202085
The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemicEuropean Journal of Heart Failure202084
Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update)Diabetes/Metabolism Research and Reviews202079
Mental health in UK Biobank - development, implementation and results from an online questionnaire completed by 157 366 participants: a reanalysisBJPsych Open202076
Acute heart failureNature Reviews Disease Primers202070
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HFJACC: Heart Failure202061
Oxidative Stress: A Unifying Paradigm in HypertensionCanadian Journal of Cardiology202057
Definitions and criteria for diabetic foot diseaseDiabetes/Metabolism Research and Reviews202057